Showing 1 - 7 results of 7 for search 'Xu-Wei Cai', query time: 0.03s Refine Results
  1. 1
    Dose-escalation by hypofractionated simultaneous integrated boost IMRT in unresectable stage III non-small-cell lung cancer

    Dose-escalation by hypofractionated simultaneous integrated boost IMRT in unresectable stage III non-small-cell lung cancer by Qin Zhang, Xu-Wei Cai, Wen Feng, Wen Yu, Xiao-Long Fu

    Published 2022-01-01
    Get full text
    Article
  2. 2
    Patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma: implications for the clinical target volume design of postoperative radiotherapy.

    Patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma: implications for the clinical target volume design of postoperative radio... by Qi Liu, Xu-Wei Cai, Bin Wu, Zheng-Fei Zhu, Hai-Quan Chen, Xiao-Long Fu

    Published 2014-01-01
    Get full text
    Article
  3. 3
    The positive role of vitronectin in radiation induced lung toxicity: the in vitro and in vivo mechanism study

    The positive role of vitronectin in radiation induced lung toxicity: the in vitro and in vivo mechanism study by Tian-Le Shen, Mi-Na Liu, Qin Zhang, Wen Feng, Wen Yu, Xiao-Long Fu, Xu-Wei Cai

    Published 2018-04-01
    Get full text
    Article
  4. 4
    Clinical impact of the tumor immune microenvironment in completely resected stage IIIA(N2) non-small cell lung cancer based on an immunological score approach

    Clinical impact of the tumor immune microenvironment in completely resected stage IIIA(N2) non-small cell lung cancer based on an immunological score approach by Wen Feng, Yuan Li, Lei Shen, Qin Zhang, Xu-Wei Cai, Zheng-Fei Zhu, Meng-Hong Sun, Hai-Quan Chen, Xiao-Long Fu

    Published 2021-01-01
    Get full text
    Article
  5. 5
    Radiomics Signature Facilitates Organ-Saving Strategy in Patients With Esophageal Squamous Cell Cancer Receiving Neoadjuvant Chemoradiotherapy

    Radiomics Signature Facilitates Organ-Saving Strategy in Patients With Esophageal Squamous Cell Cancer Receiving Neoadjuvant Chemoradiotherapy by Yue Li, Yue Li, Jun Liu, Hong-xuan Li, Xu-wei Cai, Zhi-gang Li, Xiao-dan Ye, Hao-hua Teng, Xiao-long Fu, Wen Yu

    Published 2021-02-01
    Get full text
    Article
  6. 6
    Enhancing Prediction for Tumor Pathologic Response to Neoadjuvant Immunochemotherapy in Locally Advanced Esophageal Cancer by Dynamic Parameters from Clinical Assessments

    Enhancing Prediction for Tumor Pathologic Response to Neoadjuvant Immunochemotherapy in Locally Advanced Esophageal Cancer by Dynamic Parameters from Clinical Assessments by Xin-Yun Song, Jun Liu, Hong-Xuan Li, Xu-Wei Cai, Zhi-Gang Li, Yu-Chen Su, Yue Li, Xiao-Huan Dong, Wen Yu, Xiao-Long Fu

    Published 2023-09-01
    Get full text
    Article
  7. 7
    EGFR Thr790Leu as a Potential Resistance Mechanism to First-Generation EGFR Tyrosine Kinase Inhibitor May Respond to Osimertinib in Patients With Lung Adenocarcinoma

    EGFR Thr790Leu as a Potential Resistance Mechanism to First-Generation EGFR Tyrosine Kinase Inhibitor May Respond to Osimertinib in Patients With Lung Adenocarcinoma by Chan Xiang, PhD, Wei Zhang, PhD, MD, Li-Wen Xiong, MD, Xu-Wei Cai, PhD, MD, Hao-Hua Teng, MD, Rui-Ying Zhao, MD, Zhan-Xian Shang, MD, Han Han-Zhang, PhD, Lu Zhang, PhD, Li Yan, MS, Zhi-Qiu Chen, MS, Yu-Chen Han, PhD, MD

    Published 2021-07-01
    Get full text
    Article

Search Tools: